Drug
zidesamtinib
Marketed as JIDEYTRO.
Generic name
zidesamtinib
Brand names
JIDEYTRO
First FDA approval
2026-07-22
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA220185 | JIDEYTRO | 2026-07-22 | NUVALENT INC |
Manufacturers
NUVALENT INC
Frequently asked questions
When was zidesamtinib FDA approved?
Earliest FDA approval on record: 2026-07-22.
What brand names are sold as zidesamtinib?
JIDEYTRO.
Sources
Appeal a zidesamtinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com